Which glycogen storage disease also presents as a lysosomal storage disease?
Increased uric acid levels are seen in which glycogen storage disease ?
GLUT2 plays a functionally important role mainly in?
Enzymes of glycolysis are found in:
Which of the following is an amino sugar formed from fructose-6-phosphate?
At which step in glycolysis is NADH produced during the oxidation of glyceraldehyde-3-phosphate?
Which carbohydrate is primarily metabolized by Aldolase-B?
Which of the following GAG is not sulfated?
What cofactor is required for the proper functioning of glucose-6-phosphate dehydrogenase?
Which enzyme is active when the insulin:glucagon ratio is low?
Explanation: ***Pompe's disease*** - Also known as **glycogen storage disease type II**, it is caused by a deficiency of **acid alpha-glucosidase (GAA)**, a *lysosomal enzyme*. - This deficiency leads to the accumulation of **glycogen in lysosomes**, particularly affecting muscle tissue, thereby earning its classification as both a glycogen storage disease and a lysosomal storage disease. *Von Gierke's disease* - This is **glycogen storage disease type I** and is due to a deficiency in **glucose-6-phosphatase**. - It primarily affects the **liver and kidneys**, causing severe **hypoglycemia** and **lactic acidosis**, but it is not classified as a lysosomal storage disease. *McArdle's disease* - This is **glycogen storage disease type V**, caused by a deficiency in **muscle glycogen phosphorylase (myophosphorylase)**. - It manifests as **exercise intolerance** and muscle pain, but it does not involve lysosomal enzyme defects or glycogen accumulation in lysosomes. *Andersen's disease* - This is **glycogen storage disease type IV**, caused by a deficiency in the **glycogen branching enzyme**. - It leads to the formation of **abnormal glycogen structures**, primarily affecting the liver and causing early liver failure, but it is not a lysosomal storage disorder.
Explanation: ***Type I (Von Gierke's disease)*** - In **Von Gierke's disease**, the deficiency of **glucose-6-phosphatase** leads to accumulation of glucose-6-phosphate in hepatocytes. - **Hyperuricemia** occurs due to: 1. **Increased purine degradation** - Metabolic stress leads to accelerated ATP breakdown and increased uric acid production 2. **Decreased renal excretion** - Lactic acidosis (from G6P → pyruvate → lactate) competitively inhibits uric acid secretion in renal tubules 3. **Enhanced purine synthesis** - Increased availability of ribose-5-phosphate from pentose phosphate pathway - Classic triad: **Hepatomegaly, hypoglycemia, and lactic acidosis with hyperuricemia** *Type II (Pompe disease)* - Caused by a deficiency of **acid alpha-glucosidase** (acid maltase), leading to glycogen accumulation in **lysosomes**. - Primarily affects the **heart**, **muscles**, and **liver**, but does not cause hyperuricemia. *Type IV (Andersen disease)* - Results from a deficiency of **glycogen branching enzyme**, leading to the formation of abnormal glycogen with long, unbranched chains. - Primarily affects the **liver** and **spleen**, causing cirrhosis and hepatic failure, but not hyperuricemia. *Type III (Cori disease)* - Caused by a deficiency of **glycogen debranching enzyme** (amylo-1,6-glucosidase), leading to abnormal accumulation of glycogen with short outer branches. - Presents with hepatomegaly, hypoglycemia, and muscle weakness, but **hyperuricemia is not a characteristic feature**.
Explanation: ***Pancreatic beta cells*** - **GLUT2** acts as a **glucose sensor** in pancreatic beta cells, which is its **most functionally critical role** in the body. - Its high Km (~15-20 mM, low affinity) ensures that glucose uptake is **proportional to blood glucose concentration**, enabling the beta cells to accurately sense glucose levels and secrete insulin accordingly. - This glucose-sensing mechanism is **essential for maintaining glycemic homeostasis** and makes GLUT2's role in beta cells uniquely important compared to its presence in other tissues. - Without functional GLUT2 in beta cells, the body cannot properly regulate insulin secretion in response to changing glucose levels. *Liver* - While **GLUT2** is abundantly expressed in hepatocytes and allows for bidirectional glucose transport (both uptake and release), its role here is **facilitative rather than regulatory**. - The liver has multiple other glucose-regulating mechanisms (glucokinase, glucose-6-phosphatase, glycogen metabolism). - GLUT2's function in the liver is important but not as uniquely critical as its glucose-sensing role in beta cells. *Skeletal muscle tissue* - **Skeletal muscle** primarily utilizes **GLUT4** (not GLUT2) for insulin-dependent glucose uptake. - **GLUT2** is not significantly expressed in skeletal muscle tissue. - This makes GLUT2 functionally unimportant in skeletal muscle. *Kidney* - The **kidney** expresses **GLUT2** in proximal tubule cells where it participates in glucose reabsorption from the glomerular filtrate. - However, this role is **secondary to SGLT2** (sodium-glucose cotransporter 2), which performs the primary active reabsorption. - GLUT2's function here is important but not the **"mainly"** critical role compared to its glucose-sensing function in beta cells.
Explanation: ***Cytosol*** - Glycolysis is a metabolic pathway that occurs in the **cytosol** of cells. - All the enzymes required for the conversion of glucose to pyruvate are freely dissolved in the **cytoplasm**. *Cell membrane* - The cell membrane is primarily involved in **regulating the passage of substances** into and out of the cell, as well as cell signaling. - Glycolytic enzymes are not associated with the cell membrane. *Mitochondria* - Mitochondria are the primary site of **oxidative phosphorylation** and the **citric acid cycle**, not glycolysis. - While pyruvate (the end product of glycolysis) moves into the mitochondria for further metabolism, the initial glycolytic steps do not occur there. *Ribosomes* - Ribosomes are responsible for **protein synthesis** (translation). - They do not contain enzymes for metabolic pathways like glycolysis.
Explanation: ***Glucosamine-6-phosphate*** - This amino sugar is directly synthesized from **fructose-6-phosphate** via a transamidation reaction, where an amino group replaces a hydroxyl group. - It is a key intermediate in the biosynthesis of other **amino sugars** and **glycosaminoglycans**. *N-acetylglucosamine-6-phosphate* - This is formed from **glucosamine-6-phosphate** by the addition of an **acetyl group**, making it a subsequent product, not the initial amino sugar from fructose-6-phosphate. - The N-acetylation step is crucial for its role in cellular signaling and structural components. *Galactosamine-6-phosphate* - While an amino sugar, **galactosamine-6-phosphate** is derived from UDP-N-acetylglucosamine, not directly from fructose-6-phosphate. - Its formation involves an **epimerization** step of an existing N-acetylglucosamine structure. *UDP-N-acetylglucosamine* - This is an **activated form** of N-acetylglucosamine, formed by the addition of UTP to N-acetylglucosamine-1-phosphate. - It serves as a precursor for the synthesis of complex **carbohydrates** and glycoproteins, far downstream from fructose-6-phosphate.
Explanation: ***Glyceraldehyde-3-phosphate dehydrogenase*** - This enzyme catalyzes the oxidation and **phosphorylation** of glyceraldehyde-3-phosphate, producing **1,3-bisphosphoglycerate**. - During this reaction, **NAD+ is reduced to NADH**, which is a crucial step for energy production. *Pyruvate kinase* - This enzyme catalyzes the final step of glycolysis, transferring a phosphate group from **phosphoenolpyruvate** to ADP, forming ATP and pyruvate. - This step involves **substrate-level phosphorylation** for ATP production, not NADH. *Enolase* - This enzyme catalyzes the dehydration of **2-phosphoglycerate** to form **phosphoenolpyruvate (PEP)**. - This reaction involves the removal of a water molecule and does not produce NADH. *PFK-1* - **Phosphofructokinase-1 (PFK-1)** catalyzes the phosphorylation of fructose-6-phosphate to **fructose-1,6-bisphosphate**. - This is an ATP-consuming and a crucial regulatory step in glycolysis, but it does not involve NADH production.
Explanation: ***Fructose*** - **Aldolase B** is a key enzyme in the liver responsible for the metabolism of **fructose**, specifically cleaving **fructose-1-phosphate** into **dihydroxyacetone phosphate** and **glyceraldehyde**. - A deficiency in **Aldolase B** leads to **hereditary fructose intolerance**, causing an accumulation of **fructose-1-phosphate** after fructose ingestion. *Galactose* - **Galactose** is primarily metabolized by enzymes in the **Leloir pathway**, including **galactokinase** and **galactose-1-phosphate uridylyltransferase**. - **Aldolase B** plays no significant role in the metabolism of galactose. *Sucrose* - **Sucrose** is a disaccharide composed of **glucose** and **fructose**. - It is first broken down by **sucrase** in the small intestine into its constituent monosaccharides before they are metabolized further. *None of the options* - This option is incorrect because **fructose** is indeed a carbohydrate primarily metabolized by Aldolase-B. - The enzyme's specific role in fructose metabolism is well-established.
Explanation: ***Hyaluronic acid*** - **Hyaluronic acid** is unique among glycosaminoglycans (GAGs) because it is the only one that is **not sulfated**. - It also distinguishes itself by being the only GAG that does **not form proteoglycans** and is not synthesized in the Golgi apparatus. *Chondroitin sulfate* - **Chondroitin sulfate** is a sulfated glycosaminoglycan that is a major component of the **extracellular matrix**, particularly in cartilage. - Its sulfate groups contribute to its **negative charge**, allowing it to attract water and provide resistance to compression. *Dermatan sulfate* - **Dermatan sulfate** is another sulfated GAG, found predominantly in the skin, blood vessels, and heart valves. - It contains **sulfate groups**, which are crucial for its interactions with various proteins and its role in tissue structure. *Keratan sulfate* - **Keratan sulfate** is a sulfated GAG found in the cornea, cartilage, and bone. - It is distinct from other GAGs due to its **lack of uronic acid** and the presence of sulfate groups.
Explanation: ***NADP*** - **NADP+** (nicotinamide adenine dinucleotide phosphate) acts as the **electron acceptor** in the **glucose-6-phosphate dehydrogenase (G6PD)** reaction, becoming **NADPH**. - **NADPH** is crucial for maintaining the **redox balance** in cells, particularly in red blood cells, by reducing **oxidative stress**. *NAD* - **NAD+** (nicotinamide adenine dinucleotide) is a primary cofactor for many **dehydrogenase reactions** in catabolic pathways like **glycolysis** and the **Krebs cycle**. - It primarily functions as an electron acceptor in pathways that generate **ATP**, distinct from the role of **NADPH** in reductive biosynthesis and antioxidant defense. *FAD* - **FAD** (flavin adenine dinucleotide) is a coenzyme derived from **riboflavin (vitamin B2)** that is involved in various redox reactions, often in the form of **flavoproteins**. - Enzymes like **succinate dehydrogenase** in the electron transport chain utilize **FAD** as an electron acceptor, which is not the case for G6PD. *FMN* - **FMN** (flavin mononucleotide) is another coenzyme derived from **riboflavin**, structurally similar to FAD but lacking the additional adenosine monophosphate. - It participates in electron transfer reactions, particularly within **complex I** of the **electron transport chain**, but is not a cofactor for G6PD.
Explanation: ***Glucose-6-phosphatase*** - A low **insulin:glucagon ratio** occurs during **fasting, starvation, or stress** (catabolic state). - In this metabolic state, **glucose-6-phosphatase** is **highly active** in the **liver** (and kidneys), catalyzing the final step of both **gluconeogenesis** and **glycogenolysis**. - It converts **glucose-6-phosphate** to **free glucose**, which is released into the bloodstream to maintain **blood glucose levels**. - This enzyme is stimulated by **glucagon** and inhibited by **insulin**. *Fructokinase* - This enzyme phosphorylates **fructose** to **fructose-1-phosphate** in the liver. - It is regulated by **fructose availability**, not by the **insulin:glucagon ratio**. - During a low insulin:glucagon state, **gluconeogenic** and **glycogenolytic** pathways are favored, not fructose metabolism. *Lactate dehydrogenase* - **LDH** interconverts **pyruvate** and **lactate** and functions in both **glycolysis** and **gluconeogenesis**. - While it plays a role in various metabolic states, it is **not specifically activated** by a low insulin:glucagon ratio. - It operates constitutively based on substrate availability rather than hormonal regulation. *Acetyl-CoA carboxylase* - This is the **rate-limiting enzyme** of **fatty acid synthesis** (lipogenesis). - It is **activated by insulin** (fed state) and **inhibited by glucagon** (fasted state). - When the insulin:glucagon ratio is **low**, this enzyme is **phosphorylated and INACTIVE**, shutting down fatty acid synthesis.
Carbohydrate Chemistry and Classification
Practice Questions
Glycolysis: Reactions and Regulation
Practice Questions
Gluconeogenesis: Reactions and Regulation
Practice Questions
Glycogen Metabolism: Synthesis and Breakdown
Practice Questions
Glycogen Storage Diseases
Practice Questions
Pentose Phosphate Pathway
Practice Questions
Metabolism of Fructose and Galactose
Practice Questions
Disorders of Fructose and Galactose Metabolism
Practice Questions
Blood Glucose Regulation
Practice Questions
Diabetes Mellitus: Biochemical Aspects
Practice Questions
Glycosylation and Glycoproteins
Practice Questions
Lactose Intolerance and Galactosemia
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free